ORIGINAL RESEARCH
Published on 11 Sep 2026
Inhibitory effects of cold atmospheric plasma-activated solution on cutaneous squamous cell carcinoma
doi 10.3389/fphar.2026.1921696
- 332 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Immunopharmacology in Skin Cancer: Progress, Challenges, and Future Directions
Immunopharmacology in Skin Cancer: Progress, Challenges, and Future Directions
1,204
Total downloads
9,599
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 03 Sep 2026
Molecular reprogramming in cutaneous melanoma: the central role of G9a and EZH2 methyltransferase inhibitors in tumor plasticity, immune evasion, and therapeutic resistance
doi 10.3389/fphar.2026.1879451
- 406 views
ORIGINAL RESEARCH
Published on 29 Jan 2026
A combination of low TMB and PD-L1 expression predict poor progression-free survival of metastatic melanoma patients treated with first-line ipilimumab plus nivolumab
doi 10.3389/fimmu.2026.1729883
- 1,583 views
ORIGINAL RESEARCH
Published on 16 Jan 2026
Loss of the translational repressor 4E-BP1 promotes skin carcinogenesis
doi 10.3389/fphar.2026.1742429
- 1,191 views
- 2 citations
CASE REPORT
Published on 06 Jan 2026
Hematologic immune-related adverse events in skin cancer patients treated with immune checkpoint inhibitors: a case series
doi 10.3389/fphar.2025.1717727
- 1,841 views
- 2 citations
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: